Multisystem Inflammatory Syndrome in Children associated withCOVID-19: Report of four cases in Mexico across the Mexico-USBorder

Authors

  • Enrique Chacon-Cruz Institute for Global Health, University of Siena, Italy, Department of Pediatric Infectious Diseases, General Hospital of Tijuana, Mexico Author
  • Yolanda Correa-Bautista Department of Pediatric Immunology, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico Author
  • Guadalupe Urrea-Sanchez Department of Pediatric Cardiology, General Hospital of Tijuana, Mexico Author
  • Erika Zoe Lopatynsky-Reyes Institute for Global Health, University of Siena, Italy, School of Public Health, University of California in San Diego, USA Author
  • Francisco Arnoldo ChanDzib Department of Pediatric Intensive Care, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico Author
  • Jesus Gilberto Montano-Duron Department of Pediatrics, General Hospital of Tijuana, Mexico Author

DOI:

https://doi.org/10.47363/JIDSCR/2020(1)122

Keywords:

Multisystem Inflammatory Syndrome in Children, MIS-C, COVID-19, SARS-CoV-2 Mexico

Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) is a newly described autoimmune disease mostly occurring in older children, adolescents, and young adults associated with Severe Acute Respiratory Syndrome-Coronavirus type 2 (SARS-CoV-2) infection. Several MIS-C publications from Europe and North America are available, with only a few from Latin America. This is the first Mexican publication of four case reports of MIS-C. Median age at admission was of 8.2 years. All cases manifested with fever, cutaneous rash, conjunctivitis, abdominal pain, and nausea/vomiting. All were admitted with shock, developed coronary abnormalities in the echocardiogram, and had lung abnormalities in the computerized tomography scan. Three needed medical care at the Pediatric Intensive Care Unit, all were resistant to intravenous immunoglobulin, and one patient died of severe myocarditis, shock and acute myocardial infarction. All four cases had a positive SARS-CoV-2 RT-PCR from nasopharynx.

Author Biographies

  • Enrique Chacon-Cruz, Institute for Global Health, University of Siena, Italy, Department of Pediatric Infectious Diseases, General Hospital of Tijuana, Mexico

    Institute for Global Health, University of Siena, Italy, Department of Pediatric Infectious Diseases, General Hospital of Tijuana, Mexico 

  • Yolanda Correa-Bautista, Department of Pediatric Immunology, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico

    Department of Pediatric Immunology, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico

  • Guadalupe Urrea-Sanchez, Department of Pediatric Cardiology, General Hospital of Tijuana, Mexico

    Department of Pediatric Cardiology, General Hospital of Tijuana, Mexico

  • Erika Zoe Lopatynsky-Reyes, Institute for Global Health, University of Siena, Italy, School of Public Health, University of California in San Diego, USA

    Institute for Global Health, University of Siena, Italy, School of Public Health, University of California in San Diego, USA

  • Francisco Arnoldo ChanDzib, Department of Pediatric Intensive Care, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico

    Department of Pediatric Intensive Care, Hospital #31 of the Mexican Institute of Social Security, Mexicali, Mexico 

  • Jesus Gilberto Montano-Duron, Department of Pediatrics, General Hospital of Tijuana, Mexico

    Department of Pediatrics, General Hospital of Tijuana, Mexico

Downloads

Published

2020-10-23